Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures

Journal of Neural Transmission
K K BorowiczS J Czuczwar

Abstract

This study evaluated the interactions between tiagabine (TGB) and three conventional antiepileptic drugs (AEDs): valproate (VPA), carbamazepine (CBZ), and phenobarbital (PB) in amygdala-kindled rats, a reliable model of complex partial seizures in humans. Isobolographic analysis of interactions revealed that TGB interacted additively with all tested conventional AEDs for the fixed-ratio combinations of 1:3, 1:1, and 3:1. Evaluation of pharmacokinetic interactions between AEDs revealed that the observed additivity was pharmacodynamic in nature. TGB did not affect the plasma and brain concentrations of VPA, CBZ and PB. Similarly, none of the studied conventional AEDs changed the plasma or brain levels of TGB. Also, TGB, VPA, CBZ, and PB administered alone (at their median effective doses) and in combinations at the fixed-ratio of 1:1 did not impair motor performance evaluated in the chimney test. In conclusion, additivity between TGB and conventional AEDs in amygdala-kindled rats and lack of bidirectional pharmacokinetic interactions suggest that TGB appears to be a valuable drug for an add-on therapy of refractory complex partial seizures in humans.

References

Apr 25, 1990·European Journal of Pharmacology·F PorrecaR J Tallarida
Apr 1, 1997·Current Opinion in Neurology·R L Macdonald, L J Greenfield
Jan 1, 1997·Life Sciences·R J TallaridaR B Raffa
Feb 5, 1998·Lancet·J P Leach, M J Brodie
Sep 14, 2000·Seizure : the Journal of the British Epilepsy Association·T FakhouryB Abou-Khalil
Nov 26, 2002·Epilepsy Research·Stanisław J Czuczwar, Kinga K Borowicz
Jul 17, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jarogniew J LuszczkiStanisław J Czuczwar
Jul 23, 2003·Pharmacology, Biochemistry, and Behavior·Jarogniew ŁuszczkiStanisław J Czuczwar
Feb 27, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Jarogniew J Luszczki, Stanislaw J Czuczwar
May 26, 2004·Pharmacology, Biochemistry, and Behavior·K K BorowiczS J Czuczwar
Aug 25, 2004·Seizure : the Journal of the British Epilepsy Association·Paul McKee
Nov 3, 2004·Seizure : the Journal of the British Epilepsy Association·Xiaolan WangPhilip N Patsalos
Sep 1, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Jarogniew J Luszczki, Stanislaw J Czuczwar

❮ Previous
Next ❯

Citations

Jul 6, 2014·Seizure : the Journal of the British Epilepsy Association·Ting WuTakahisa Hanada
Jul 7, 2011·Prevention Science : the Official Journal of the Society for Prevention Research·Katie A McLaughlin
Aug 21, 2013·Pharmacological Reports : PR·Anna SerefkoEwa Poleszak
Mar 29, 2011·Pharmacological Reports : PR·Francisco J BarbosaRoberto Andreatini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.